GT-005

N/A

Report date: 2024/07/09 20:00:06

Base Information

Drug NameGT-005
Drug Alias NameGT-005
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV2 vector
Mechanisms of ActionComplement C1 modulators
TargetsComplement C1
Therapy Area/IndicationsAnetodermaGeographic AtrophyMacular Degeneration +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandNetherlands +[8] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGyroscope Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma AgGyroscope Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsAnetodermaGeographic AtrophyMacular Degeneration +[6] 

Other Information

ATC CodeN/A
Related LinksN/A